Neutrophilic eccrine hidradenitis associated with decitabine.
Ng
Esther S
ES
Aw
Derrick C
DC
Tan
Kong Bing
KB
Poon
Michelle L
ML
Yap
Eng Soo
ES
Liu
Te Chih
TC
Tan
Lip-Kun
LK
Chng
Wee Joo
WJ
Koh
Liang-Piu
LP
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001374:Azacitidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D003622:Dapsone / Q000627:therapeutic use; D000077209:Decitabine; D005260:Female; D016575:Hidradenitis / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D003622:Dapsone; D011239:Prednisolone; D001374:Azacitidine